Ethnopharmacology – From Mexican Hallucinogens to a Global Transdisciplinary Science by Heinrich, M & Casselman, I
The Ibogaine Project: Urban Ethnomedicine for Opioid Use Disorder
Kenneth Alper
160
Psychoactive Initiation Plant Medicines: Their Role in the Healing and 
Learning Process of South African and Upper Amazonian Traditional 
Healers 
Jean-Francois Sobiecki
175
Psychoactive Australian Acacia Species and Their Alkaloids
Snu Voogelbreinder
181
From ‘There’ to ‘Here’: Psychedelic Natural Products and Their 
Contributions to Medicinal Chemistry [Keynote]
David E. Nichols
202
MEXICO & CENTRAL AMERICA 219
Fertile Grounds? – Peyote and the Human Reproductive System
Stacy B. Schaefer
220
Mescal, Peyote and the Red Bean: A Peculiar Conceptual Collision  
in Early Modern Ethnobotany
Keeper Trout
234
Reflections on the Peyote Road with the Native American Church 
– Visions & Cosmology
Jerry Patchen
257
BIOSPHERE 281
Phylogenetic Analysis of Traditional Medicinal Plants: Discovering 
New Drug Sources from Patterns of Cultural Convergence
Jeanmaire Molina
282
Ethnopharmacology Meets the Receptorome: Bioprospecting  
for Psychotherapeutic Medicines in the Amazon Rainforest
Dennis McKenna
295
A Preliminary Report on Two Novel Psychoactive Medicines from 
Northern Mozambique 
Dale Millard
313
Ethnopharmacology – From Mexican Hallucinogens to a Global 
Transdisciplinary Science [Keynote]
Michael Heinrich
316
Afterword
Mark Plotkin
324
abstract
Psychoactive natural substances have been reported from practically all regions of the world, but 
Mexican indigenous cultures have played a crucial role having influenced medical, toxicological, 
biological, chemical, pharmaceutical, and, of course, anthropological research. 
Especially in the 1950’s and 1960’s peyotl, teonanacatl and other psychoactives came to the at-
tention of researchers and revelers alike. In this overview we highlight the developments of ethno-
pharmacology from the initial development of the term until today using one psychoactive species 
as an example - Salvia divinorum. In 1962 “ethnopharmacologists”, Albert Hofmann and R. Gordon 
Wasson, documented and collected a flowering specimen of Ska María Pastora allowing the species 
botanical description as Salvia divinorum Epling & Játiva. Five years later Efron et al. (1967) organised 
a symposium “Ethnopharmacologic search for psychoactive drugs” which over the next decades 
would give its name to a discipline which today is much more broadly defined, dealing with local 
and traditional medicines, their biological activities and chemistry. Globalisation has resulted in a 
world-wide commodification of many traditional medicines and psychoactives, as exemplified by 
S. divinorum. This fascinating Lamiaceae has become globally recognized for its best known active 
constituent salvinorin A, a kappa-opioid antagonist which has a unique effect on human physiol-
ogy.
While today ethnopharmacology is a thriving discipline, the interest in psychoactive substances 
is no longer central to the discipline. The search for anti-cancer agents (which also started in earnest 
in the 1960’s) had been of particular relevance and today includes among its many foci:
• The scientific study of local and traditional knowledge not only in remote re-
gions, but for example, also in urban immigrant communities
• Research linking ethnopharmacology to biodiversity research both in terms of a 
sustainable use of natural resources (ecosystems)
• Pharmacological studies with the aim of understanding the effects of complex 
mixtures on specific diseases or disease targets
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• The safety of herbal medicines
• Anthropological and historical approaches on the use of medicinal and food 
plants and the link between food and medical uses of plants and fungi. 
50 years on ethnopharmacology is very different from what D. Efron and colleagues had envi-
sioned. 
introduction
To the best of our knowledge, the term “ethnopharmacology” was first published in 1967 by 
Efron and colleagues who used it in the title of a book on hallucinogens: “Ethnopharmacological 
Search for Psychoactive Drugs” (Efron, et al., 1970; Holmstedt, 1967). Thus with this book, we cel-
ebrate both 50 years of a ground-breaking symposium and the introduction of a new term. This 
introduction is much later than, for example, the term ethnobotany which in 1896 was coined by 
the US-American botanists William Harshberger describing the study of human’s plant use. Both 
ethnopharmacology and ethnobotany investigate the relationship between humans and plants in 
all its complexity. “Ethnopharmacology” also replaced the many other terms which had been used 
previously like “Pharmakoëthnologie” used already by Tschirch (1910) in his classic “Handbuch der 
Pharmakognosie” or pharmacoetnologia or Aboriginal botany. (cf. Heinrich, 2014). 
However, there is considerable variation in terms for what constitutes ethnopharmacology. In a 
book edited in 2015 by the first author and Prof. Anna Jaeger (Heinrich and Jaeger, 2015), we compiled 
definitions of ethnopharmacology as they were given by the contributors to this book. The range 
from definitions which are very much embedded in the: 
• Sociocultural sciences [e.g. Dan Moerman (USA): Ethnopharmacology is the 
study of the way people use plants, informing us about the varying ways people 
create meaning about these living objects.];
• Biomedical research [eg. Pravit Akarasereenont (Thailand): “A science dealing 
with the study of the pharmacology of traditional medicine and focusing on the 
active substances and their pharmacological action.” or Thomas Efferth (Germa-
ny): “Ethnopharmacology focuses on research on efficacy, safety, and modes of 
actions of traditional medicines with pharmacological methods.”]
In general the multidisciplinary of the field is highlighted very well clearly recognized by [e.g. 
Tony Booker (UK): The study of the historical and modern interactions between humans and flora, 
fauna and minerals and how these substances, their extracts and the chemical compounds derived 
from them, may be utilised to prevent and treat ill-health in people and their dependent animals]. 
Others stress the link between local and traditional knowledge with research conducted by aca-
demically trained investigators, with – in our view – Graham Jones (Australia) expressing it most 
eloquently and clearly: “Ethnopharmacology constituting a respectful marriage between modern 
science and ancient wisdom with much to be gained in both directions.”1
Consequently, ethnopharmacology is not a very sharply circumscribed field of research and is 
heavily influenced by the academic, cultural and political background of a researcher. 
In the beginning, the discipline of ethnopharmacology was focused primarily on the study of 
the traditional use psychoactive substances. However, the trajectory of this discipline has expanded 
in to an array of studies. We explore one of the early ethnopharmalogical studies, the discovery, 
description and chemical elucidation of the Mexican Lamiacea Salvia divinorum. While this species 
is not as famous as other Mexican psychoactives such as Psilocybe mushrooms, it does demonstrates 
one of the earliest ethnopharmacological studies, as well as a 50 year trajectory of discovery, from 
the description of the plant to its genetic profiling.
There can be no doubt that in 2018 ethnopharmacology is a thriving discipline, embedded in 
a range of larger disciplinary contexts like botany, pharmacy, anthropology, and medicine. Estab-
1.  Note added by Editor, Dennis McKenna. My personal favourite definition is that proposed by Holmstedt and Bruhn (1983): 
“The interdisciplinary scientific exploration of biologically active agents traditionally employed or observed by humans.” In 
my opinion this definition is succinct, specific and sufficient, in that it notes that ethnopharmacology is not restricted to medi-
cines, nor to plants, or to substances ingested, but also correctly restricts the discussion to “traditional use.”
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lished journals now publish thousands of articles in this field of research and while there are not 
many institutes that have the term in their name, many groups based in the pharmaceutical, bio-
logical, chemical and other schools publish in the field. This is impressive for a field that has had a 
surprisingly short history. 
the early years
While research on local and traditional plants dates back many centuries and includes, for ex-
ample, the many explorers “discovering” exotic treatments, the modern history is a post-World-War 
II development. The 1950’s and 1960’s saw a dramatic socio-cultural change in “Western” societies. 
As part of the opening up of the rigid post-WW2 societies, numerous new developments in the cul-
tures including music, the performing, and visual arts, but also tremendous socio-cultural conflicts 
formed new societal perspective. A key element of this was a fast developing interest in psychedel-
ic substances, most importantly hallucinogenic plants. For example, in the 1960’s and 1970’s the 
psychologist and prolific writer Timothy Leary (1920 - 1996) impacted on the political and societal 
thinking on mind-altering drugs including most notably LSD and those which were derived from 
traditional and local knowledge (especially Psilocybe spp.). With the group’s experiments on psyche-
delic substances during his “Harvard Years” (1960 – 1963), Timothy Leary may have had more impact 
on what later one was called ethnopharmacology, than we are aware of. 
Cannabis and products derived from it became an important element of this (counter-)culture. 
A key role in this context played research on and experiences with hallucinogenic plants and fungi 
from modern day Mexico, The highly toxic Toloatzin or Jimson weed Datura stramonium L. (Solana-
ceae) is one of the main and widely distributed hallucinogenic plants and fungi of Mesoamerica 
(together with peyotl - Lophophora williamsii (Lem. ex Salm-Dyck) J.M. Coult., ololiuhqui – Turbina 
corymbosa (L.) Raf.and the mushrooms teonanacatl – Psilocybe spp.); all have long traditions of use as 
hallucinogens. The following example, however, was only discovered by Western societies in 1962 - 
Salvia divinorum. It sparked great interest both in scientific terms and by those interested in its use. 
While no detailed historical information is available, it is clear that this discovery also contributed 
to the interest in holding the symposium at the University of California, San Francisco Medical Cen-
ter (January 28-30 1967) and, therefore, to the book by Efron et al (1967, republished 1970) 
salvia divinorum 
In 1962, ethnopharmacologists, Albert Hofmann and R. Gordon Wasson, undertook an expedi-
tion to Oaxaca, México (Hofmann, 1980; Wasson, 1962). Their main informants in the region became 
a curandera – Maria Sabina – who later became first persecuted and then famous. She provided the 
essential link between Mazatec traditional culture and the ‘explorers’. On this trip, they recorded 
several different plants and their use by Mazatec healers. As well as recording the cultural uses, they 
attended ceremonies, which incorporated the use of S. divinorum Epling & Jativa, a member of the 
Lamiaceae (Labiatae). This expedition contributed much to the early understanding of the cultural 
role and use of this species. Wasson and Hofmann were also able to obtain a flowering specimen of 
this plant, making the scientific description of S. divinorum possible (Epling and Jativa 1962; Cas-
selman et al 2014). This “discovery” was met with great excitement and led to a flurry of research in 
ethnopharmacology, phytochemistry, neuropharmacology and other disciplines. 
Many years later, in 1982, Ortega and his team (Ortega, Blount, and Manchand, 1982) isolated and 
identified the main active compound in S. divinorum, salvinorin A. In the early 1990s, the psycho-
active properties of salvinorin A were elucidated (Siebert, 1994). With the confirmation of its psy-
choactivity, the cultural adoption of S. divinorum as a “new” psychoactive, outside of Mexico, gained 
considerable momentum.
the botany of salvia divinorum
All recorded native populations of S. divinorum are in Oaxaca, southern Mexico. This state is bor-
dered by the Pacific Ocean to the west and, in the north, the Sierra Mazateca mountain range. Much 
of this mountain range is covered by tropical montane cloud forest (Ott, 1995, 1996; Reisfield, 1993), 
an ecosystem typified by high humidity and persistent cloud cover. Growing in the understory of the 
forest, S. divinorum has been found in several locations between 500 and 1500 meters altitude (Ott, 
1995, 1996). Populations of this plant are mostly found near water courses in partial or full shade and 
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grow in moist, nutrient-rich soil. In these conditions, S. divinorum grows and reproduces primarily 
vegetatively, flowering sporadically when enough sun penetrates the forest canopy (Reisfield, 1993).
S. divinorum grows up to 1.5 m in height and has a hollow, quadrangular stem, which is green, 
translucent and crisp (Ott, 1996; Reisfield ,1993). The leaves are 10–25cm long, 5–10 cm wide, and are 
opposite on the stem, elliptic in shape and have serrated margins (Epling and Jativa 1962; Ott 1996; 
Reisfield 1993). Numerous glandular and non-glandular trichomes are present on the leaf surface 
(Kowalczuk, et al., 2013; Siebert, 2004). The flowers have white corollas with purple calices. The flow-
ers are three to four centimeters in length and grow on panicles of 20 to 30 flowers. According to re-
ports on wild populations, as well as laboratory experiments, S. divinorum does not produce flowers 
on a regular, seasonal basis (Reisfield, 1993; Valdés, et al., 1987). In Oaxaca, this plant is observed to 
flower between October and June (Reisfield, 1993). Flowering is initiated by set durations of uninter-
rupted darkness greater than 12 hours (Reisfield, 1993). In laboratory experiments, it has been found 
that if plants are exposed to light during a dark period, flowering is aborted and the plant returns to 
vegetative growth (Reisfield, 1993).
There is limited information on the sexual reproduction of S. divinorum, however, it is very adept 
at clonal propagation both naturally and anthropogenically. On the basis of the reported reproduc-
tive behaviour of S. divinorum, it has been suggested that the more recent evolutionary trajectory of 
this plant may have been influenced by humans (Reisfield, 1993). It is hypothesized that S. divinorum 
may have been translocated from its original environment at some point in history, however, this 
has not been confirmed nor have other populations of S. divinorum been discovered in the Americas 
(Reisfield, 1993). The pollination vector for S. divinorum is also uncertain. It has been suggested that 
the pollination may be ornithophilous (Reisfield, 1993). This is corroborated by the dimensions of 
the corolla as well as the sugar content and the volume of nectar produced (Reisfield ,1993).
history of salvia divinorum
Until 1964, the use of S. divinorum appears to have been confined to the Mazatecs, an indige-
nous Mexican group located in northeast Oaxaca. The name Mazatec or Mazateca is said to mean 
“Lords of the Deer,” and was the name given to this group by the Aztec (Mooney, 1911). After Span-
ish colonization in the 1500s, the Dominicans and Jesuits began to convert indigenous peoples to 
Catholicism (Mooney, 1911). Although Spanish attempts at conversion were largely successful, the 
Mazatec also maintained their traditional beliefs, which are still practiced today (Hofmann, 1990, 
1980; Mooney, 1911; Ott, 1996). The Mazatec employ three main plants with psychoactive properties 
as part of their spiritual practices. These include Psilocybe spp. mushrooms, the seeds from Ipomoea 
violacea L. (morning glory) and the leaves of S. divinorum (Allen, 1994, 1997; Foster, 1984; Schultes, 
1969). Mazatec use of S. divinorum takes place primarily during healing and divination ceremonies, 
as well as in the training of medical practitioners (Giovannini and Heinrich, 2009).
There are four illnesses for which Mazatecs are known to have used S. divinorum (Johnson, 1939; 
Ott, 1996; Prisinzano, 2005; Valdés, Diaz, and Paul, 1983). First, this plant is often employed to cure 
eliminatory dysfunction such as diarrhoea. Secondly, people who are near death can be given an in-
fusion of the plant’s juices as a palliative, after which it is reported that the patient often recuperates 
for a short time. Thirdly, S. divinorum, in small doses, is used to cure headaches and rheumatism. 
Finally, it is given to cure a Mazatec illness known as panzón de arrego or a swollen belly. This Mazatec 
illness is believed to be caused by a curse from a brujo, (male witch) someone who practices black or 
evil magic (Prisinzano, 2005; Ott, 1996; Valdés, Diaz, and Paul, 1983; Johnson, 1939). 
S. divinorum is tended in secret groves, deep within the forest, by medicinal practitioners known 
as a curandero (male) or curandera (female) (Reisfield, 1993). It is planted in rich, black soil at the 
bottom of a gully, usually in close proximity to a stream (Diaz, 2013). Cuttings can be taken from 
the mother plant and planted directly into the moist soil, however, this plant will also root itself, 
if a branch breaks off and falls on the ground (Beifuss, 1997). Although these S. divinorum groves 
may be natural, it is difficult to determine the extent of human influence (Ott, 1996; Reisfield, 1993). 
The locations are well-protected by each individual curandero or curandera to avoid theft, and more 
importantly, contamination by malicious magic (Johnson, 1939). The large, mature leaves of S. divi-
norum are harvested by pinching the petiole of the leaves close to the main stem of the plant. The 
leaves are either eaten or crushed into a fine pulp using a mortar and pestle, and then infused in 
water (Campbell, 1997; Valdés, 2001).
Mazatec curanderos and curanderas are trained through an informal apprenticeship, during 
which they are led through a series of progressive visions by an experienced teacher (Valdés, Diaz, 
and Paul, 1983; Diaz 1979). These visions are initiated by the three psychoactive plants mentioned 
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previously and are an integral part of training. Over a period of two years, curanderos and curand-
eras ingest these plants at regular intervals to integrate the knowledge from their experiences into 
their practice (Valdés, Diaz, and Paul, 1983). Initially, trainees ingest increasingly larger doses of S. 
divinorum leaves, which show them the way to heaven, where the initiated learn from the tree of 
knowledge (Valdés, Diaz, and Paul, 1983).
During consumption of S. divinorum, either the leaves are chewed or the juice from crushed 
leaves is infused in water and ingested as a liquid (Diaz, 2013, 1979; Valdés, 2001). These ceremo-
nies are led by a curandero or curandera, and last approximately two to three hours, during which 
time the participants, who ingested the plant, are guided through different states of consciousness 
(Schultes, Hofmann, and Rätsch, 2001; Ott, 1996; Valdés, Diaz, and Paul, 1983; Hofmann, 1980, 1990; 
Estrada, 1977; Schultes, 1976). These ceremonies take place at night in a dark and remote location to 
prevent disruptions (Valdés, 2001; Valdés, Diaz, and Paul, 1983; Diaz, 1979), as absolute quiet is con-
sidered essential to the success of the ceremony. Several leaves are rolled into cigar-shaped tubes, 
chewed and swallowed. If the participant is unable to chew the leaves or manage the bitter taste, he 
or she is permitted to drink juice-infused water instead (Estrada, 1977). During each ceremony, there 
is one person present who does not ingest S. divinorum. It is the role of this person to watch over 
the ceremony and prevent any harm to participants (Diaz, 1979; Valdés, Diaz, and Paul, 1983). After 
the effects of S. divinorum have worn off, the curandero or curandera will often bathe the participant 
in the juice of the leaves (Valdés, 2001), which is said to end the effects of the experience (Valdés, 
Diaz, and Paul, 1983). After the ceremony, participants are “debriefed”; this dialogue helps to ex-
plain the meaning of their visions and ensure the success of the ceremony (Diaz, 1979; Estrada, 1977; 
Hofmann, 1990; Valdés, Diaz, and Paul, 1983).
The Spanish chronicled many of the rituals, which employed psychoactive plants, but very little 
about S. divinorum was recorded. One reason for this could be that the Mazatecs have several names 
for S. divinorum. In their native language it is referred to as Ska Maria Pastora, Ska Maria, Ska Pasto-
ra, and in Spanish it is called Hojas de Maria Pastora, Hojas de la Pastora, Hoja de adivinación, Hi-
erba Maria or La Maria (Valdés, 2001; Valdés, Diaz, and Paul, 1983; Schultes, 1972; Wasson, 1962). The 
Mazatecs associate this plant with the Christian saint, Mary (Valdés, Diaz, and Paul, 1983), however, 
the reference to her as a shepherdess is not consistent with Christian mythology (Wasson, 1962). 
This name may reflect an interpretation of a pre-contact description of the plant that was later in-
corporated into Christian beliefs (Ott, 1995). 
In the scientific literature, S. divinorum has not received as much attention as the other plants 
used by the Mexican indigenous peoples including the Mazatec; the seeds of the morning glory Ip-
omoea violacea and hallucinogenic mushrooms Psilocybe spp. (Valdés, 2001; Valdés, Diaz, and Paul, 
1983; Schultes, 1970). S. divinorum was first mentioned in western academic literature in 1939 by an-
thropologist J. Johnson (Johnson, 1939). In 1945, B. Reko reported a “magic plant” used by the Maza-
tecs called “hoja de adivinación” or “the leaf of the prophecy”, indicating that the indigenous people 
used this plant to produce visions (Valdés, Diaz, and Paul, 1983; Diaz, 1979; Schultes, 1967). Seven 
years later in 1952, R. Weitlander reported “yerba de Maria” used by curanderos in Oaxaca (Weitlander, 
1952). The first botanical specimen of S. divinorum was collected by A. Pompa, a Mexican botanist. He 
described this plant as “xka [sic] Pastora” however, he was unable to collect a flowering specimen at 
the time leaving his collection only identified to the genus level (Pompa, 1957). 
R. Gordon Wasson was a very important ethnopharmacologist and chronicler of psychoactive 
plants, especially those used by the Mazatec people. Wasson is best known for his research on the 
traditional Mexican use of Psilocybe spp. mushrooms. In July 1961, during his second expedition to 
Mexico, Wasson participated in an S. divinorum ceremony along with Albert Hoffman, known for 
his discovery of lysergic acid diethylamide or LSD (Reisfield, 1993; Hofmann, 1980; Wasson, 1962). In 
doing so, Wasson and Hoffman were the first western academics to participate in, and record, this 
ceremony. In December 1962, Wasson and Hoffman successfully collected a flowering sample of S. 
divinorum, which was classified by Carl Epling as a new species (Epling and Jativa, 1962). Contrary 
to popular belief, the first living S. divinorum specimen to be propagated outside Mexico was not 
collected by Wasson and Hoffman, but by psychiatrist and ecologist, Sterling Bunnell, who, in 1962, 
brought back a living S. divinorum specimen to UCLA Davis from an expedition to Oaxaca (Siebert, 
2003).
Research on the effects of salvinorin A on its molecular target, the kappa-opioid receptor, has 
been extensive since it represents the only known non-nitrogenous kappa-opioid receptor selective 
agonist (Casselman, et al., 2014).
In conclusion, S. divinorum was “discovered” just five years prior to the symposium on ethno-
pharmacology. We have no information on the links between these “discoveries” and the developing 
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plans for such a symposium. It may well be timely, to start a historical project on academic and 
social developments in the USA and beyond driven by the ethnopharmacologic search for psycho-
active substances .
ethnopharmacology 50 years on
Returning to the ethnopharmacology at the end of the 2nd decade of the third millennium, eth-
nopharmacology today has a very different focus and interest. In the years after the symposium, it 
seems that only limited research was going on, aside from studies on psychoactive plants and fungi 
as exemplified by S. divinorum. 
The next key event was the launch of the Journal of Ethnopharmacology in1979, which was found-
ed by Laurent Rivier and Jan G. Bruhn. Here the scope shifted to “a multidisciplinary area of re-
search concerned with the observation, description, and experimental investigation of indigenous 
drugs and their biological activity” (Rivier and Bruhn, 1979). Eleven years later the 1st International 
Congress on Ethnopharmacology was held in Strasbourg, France (5-9 June 1990) and since then 18 
conferences have been held on four continents, all organized by the International Society for Eth-
nopharmacology (ISE - http://www.ethnopharmacology.org/), which was originally founded in 1990 
in Strasbourg. In 2013 the Society for Ethnopharmacology, India was founded affiliated to the ISE. 
Research is conducted in numerous institutions and most active are many of the fast emerging 
economies especially in Asia (most notably China, but also India, South Korea, Thailand, and other 
ASEAN countries, some African (South Africa) and American countries (esp. Brazil). Clearly, the 
Journal of Ethnopharmacology is the leading journal in the field today. In its first year (1979) 29 articles 
were published, ten years later (1989) this had risen to 85, in 1999 to 205, and in 2009 to 465, with 2016 
seeing 649 published articles. Overall, at the time of writing (August 2017) just over 9600 articles 
have been published in the Journal of Ethnopharmacology alone. 
The main areas of research today are on antioxidant, anti-inflammatory and anticancer agents 
(Table 1). The vast majority of these are in vitro or in vivo studies. In recent years more clinical studies 
on traditional preparations (often small and not well designed) have also been conducted. Studies 
describing the use of medicinal and other useful plants are another element of research in the field 
of ethnopharmacology, and these are often conducted with the goal that they lead to an experimen-
tal study of some of these botanical drugs (cf. Heinrich, et al., 2017). At the same time, it is notewor-
thy that psychoactive and other effects on the CNS have not been of that much importance (Yeung et 
al 2018). However, one must also acknowledge that this measure (i.e. keywords used in Medline) is a 
relatively crude one, most importantly, because research which later on focuses on pure compounds 
or well-defined extracts may not be coded in such a way that it is visible in this comparison. 
Antioxidant 2057 Malaria 588
Inflammation 2054 Urinary 411
Cancer 2026 Central nervous system 310
Infecti$ 1971 CNS 165
Food 1600 psychoactive 62
Diabetes 1546 hallucinogen$ 64
Skin 1089 Cosmetic$ 188
Gastrointestinal 826 Fertility 156
Respiratory 638 aphrodia$ 111
Table 1 Main topics covered in ethnopharmacological research (number of hits): Medline database search 
(13/05/2017) combing “Ethnopharmacology or traditional medicine” with specific therapeutic areas as specified. 
(Ethnopharmacology or traditional medicine): 21,697 [Ethnopharmacology only: 11,607] and …..:
core challenges
Plants (and animal) based medicines are an integral part of indigenous medical systems in many 
regions of the world, and form a part of the traditional knowledge of a culture. While the focus of the 
symposium which gave ethnopharmacology its “modern” name and the current areas of research 
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differ, it is the conviction of the authors of this paper, that the commonality is in the hope that this 
research will not only provide scientific evidence both in socio-cultural as well as in biomedical 
terms but that it will help in empowering people, recognising their autochthonous traditions and 
enabling them to make the best use of such knowledge. 
A key criticism the field had to engage with is the accusation of exploiting local and traditional 
knowledge without fair and appropriate benefits to the regions of origin and the original keepers 
of this knowledge and practice. However, scientists have been the first to highlight the inextrica-
ble link between cultural and biological diversity. In 1988 a group of dedicated scientists involved 
in research on local and traditional uses of plants and biodiversity conservation and with strong 
interest in supporting indigenous and local peoples called for the recognition of indigenous rights 
and for increased support for research on ethnobiological inventories, on conservation and man-
agement programmes – resulting in the Declaration of Belem (Posey and Dutfield, 1996). Four years 
later, in 1992, the Convention on Biological Diversity (Rio Convention) was signed and has since been 
amended in numerous treaties and protocols, most recently (2010) the Nagoya Protocol (Nagoya Pro-
tocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utiliza-
tion (ABS) to the Convention on Biological Diversity). This development is both driven by the historical 
experience of many countries, and as importantly, indigenous peoples in exploitative extractions of 
biodiversity. Ethnopharmacology was one of the disciplines both involved the debate and affected 
by the resulting legal changes. 25 years after the Convention on Biological Diversity and 50 years 
after San Francisco conference that led to a named new field of research, there are still no examples 
where research and the requirements for benefit sharing have resulted in concrete and long term 
benefits to the regions or countries of origin.
In the last 25 years, numerous efforts have focused on translating the principles of this treatise 
into best practice. However, examples of problematic or poor practice also abound. We continue to 
have a very complex and critical debate about who benefits from this research and on how we best 
follow the ethical guidelines which in this field are most prominently, based on the Convention on 
Biological Diversity (the Rio Convention, 1992) and subsequent agreements. An understanding of 
these efforts needs to be based on the fast changing framework, and for example, the Sustainable 
Development Goals directly impact on the research and development needs globally. Consequently, 
modern ethnopharmacological research provides new evidence for old preparations and contrib-
utes to primary health care (Heinrich 2010). How to best achieve this is still in its infancy and we – as 
scientists – have still not achieved large scale contributions to improving healthcare globally.
In this regard ethnopharmacology is embedded in a wider debate about the historical and future 
role of traditional medicines and medical systems globally. In 2016 some systems of traditional med-
icine (TM) were included in the 11th edition of the International Classification of Diseases (ICD-11), 
providing a strong impetus both for closer links between traditional medicines and biomedicine, 
but also adding new responsibilities to practitioners of TM and to those who investigate such med-
ical systems
Ongoing debates relate to best practice in the field (e.g. Cos, et al., 2006, Heinrich, et al., 2017). 
Here concerns about what constitutes best practice in terms of concepts and methods are addressed 
and clearly, there is a need to improve the methods we use in data acquisition and analysis. These 
debates are shared with many other fields of research, and, for example, best practice in pharmaco-
logical research is an important concern in many areas of the discipline. Biomedical research that 
cannot be reproduced or which is of poor quality or which is poorly reported will ultimately under-
mine the credibility, relevance, and sustainability of the research process in general (e.g. Mullane, 
et al., 2015).
conclusion
This volume celebrates the fiftieth anniversary of a very important conference, and in this pa-
per, we have looked beyond the scope “ethnopharmacology” covered at its start. While one must 
acknowledge that psychoactive natural substances are no longer at the center, the detailed look at 
the history of the discovery of Salvia divinorum by Western science and society has been an import-
ant driving force not only leading the conference (Schultes, 1967), but has continued with a flurry 
of neuropharmacological research on the species and its active metabolites. As such it exemplifies 
how ethnopharmacology links the study of local knowledge and practices and bio-scientific and 
biomedical investigations. Today’s research is thriving but also the conflict exemplified in the his-
tory of “discovering” and researching Salvia divinorum are a part of the current scenario. Research 
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in ethnopharmacology must, by definition be interdisciplinary, or preferably transdisciplinary, and 
applying these findings in prevention and treatment should be an element of such research.
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